Fibrinogen treatment for severe bleeding after trauma
Part of Blood & lymphatic, Genetic & congenital, Injuries & trauma clinical trials.
This study tests an investigational treatment called INTERCEPT Fibrinogen Complex (IFC) for people with severe bleeding after a traumatic injury. The treatment helps restore a key blood-clotting protein to try to stop the bleeding and improve survival.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 or older (or weigh at least 110 pounds if age isn't known)
- Have a serious injury from an accident or trauma
- Get to the hospital within about 1 hour of the injury
- Have heavy bleeding that requires a blood transfusion right away
- Have low levels of a clotting protein (fibrinogen) in the blood
- Not have certain serious conditions (like isolated brain injury, burns over 20% of the body, or be known to be pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving factor XIII, a natural protein that helps blood clot, can reduce excessive bleeding after vaginal delivery. It is for women who are at least 30 weeks pregnant with a single baby and who do not have certain medical conditions.
This Phase 2 trial studies whether giving antithrombin can better prevent harmful blood clots (venous thromboembolism) after serious injuries. The goal is to reduce clot risk while you’re in the trauma ICU or step-down unit.
This trial checks if a fast bedside test for fibrinogen (a protein that helps blood clot) can help guide treatment for trauma patients who are actively bleeding. It may lead to better care in the emergency department.
This trial tests whether giving fibrinogen, a protein that helps blood clot, reduces bleeding during liver transplant surgery. It may help patients with certain liver conditions who are at higher risk of bleeding.
This trial tests whether giving fresh frozen plasma (a blood product) soon after a traumatic brain injury can help people recover better. It is for adults aged 18 to 65 with moderate to severe TBI confirmed by CT scan.
This trial studies how well the body's natural clot-busting system works in people with serious infections or major injuries. It may help doctors find better ways to treat these conditions.
Hear when a new Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.